Hacker News Board Hacker News, browsed like a classic message board
Live data from Hacker News

Launch HN: InpharmD (YC W21) – curated drug information for doctors

news.ycombinator.com

Post reply on HN
Print view View original

41–50 of 74 posts

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#41

Post by sterlinm »

aadvani wrote: post #36
treis wrote: post #34

Earlier quoted context omitted.

>It'd be great if a service like this helps doctors discover treatments for less than common conditions. Isn't that what Up To Date is?

Despite their best efforts, up to date can never truly be up to date, can they? No shade, we love up to date; we just see ourselves as a complement.

I mentioned this to my wife (she's a research physician) and her first response was also "isn't that what Up to Date does?"

How would you characterize the difference between InpharmD and UpToDate? Different features? Better execution?

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#42

Post by aadvani »

Herodotus38 wrote: post #35
aadvani wrote: post #31

Earlier quoted context omitted.

Also, we actually did this one, if you’re curious: https://www.inpharmd.com/is-there-any-data-to-support-higher...

Thanks for the link. Anecdotally in our hospital only one patient to my knowledge has survived after a higher dose of dexamethasone (this was only used after the patient was worsening despite the standard 10 days of 6 mg dexamethasone). Whether this helped them or they were going to improve despite can't be known. I would also be careful about how you use the term atypical, in fact most patients with COVID are typica…

Great info, and a shame there’s not better real world evidence for cases like this. And I hear you, just making the point that most shouldn't be considered “typical”; we should question everything.

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#43

Post by sterlinm »

sterlinm wrote: post #41
aadvani wrote: post #36

Earlier quoted context omitted.

Despite their best efforts, up to date can never truly be up to date, can they? No shade, we love up to date; we just see ourselves as a complement.

I mentioned this to my wife (she's a research physician) and her first response was also "isn't that what Up to Date does?" How would you characterize the difference between InpharmD and UpToDate? Different features? Better execution?

Sorry I see you answered below!

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#44

Post by aadvani »

sterlinm wrote: post #41
aadvani wrote: post #36

Earlier quoted context omitted.

Despite their best efforts, up to date can never truly be up to date, can they? No shade, we love up to date; we just see ourselves as a complement.

I mentioned this to my wife (she's a research physician) and her first response was also "isn't that what Up to Date does?" How would you characterize the difference between InpharmD and UpToDate? Different features? Better execution?

Yep, totally. But they have X credible authors so can only have X credible info on their site.

This means they focus on the most common questions.

Public data/ our data shows point of care references like UTD can only answer ~1/2 of clinical questions.

We’re building our tool for the other 1/2.

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#46

Post by aadvani »

Jommi wrote: post #33

Isnt this like the recent GlacierMD? https://news.ycombinator.com/item?id=21947551 https://news.ycombinator.com/item?id=25921697

Same problem, for sure, but we’re taking a different approach.

A SAAS tool has a hard time with complex questions because healthcare data is messy and results will be imperfect.

Therefore we feel strongly about building a human - lead service thats optimized by software.

Every health system employs clinical pharmacists to manually do this today, so we use that as our stake in the ground, and so far we’re finding we’re way more efficient.

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#47

Post by Jommi »

aadvani wrote: post #46
Jommi wrote: post #33

Isnt this like the recent GlacierMD? https://news.ycombinator.com/item?id=21947551 https://news.ycombinator.com/item?id=25921697

Same problem, for sure, but we’re taking a different approach. A SAAS tool has a hard time with complex questions because healthcare data is messy and results will be imperfect. Therefore we feel strongly about building a human - lead service thats optimized by software. Every health system employs clinical pharmacists to manually do this today, so we use that as our stake in the ground, and so far we’re finding we’r…

Yes I think you're approaching it from a way better angle.

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#48

Post by aadvani »

euthymiclabs wrote: post #45

Love this! I was just trying to search for studies on weight gain in a very uncommon medication. I'll have to pester my institution about this.

Thank you! This is exactly the type of question we’re here for.

You can create a free trial account here and ask your question, all in 30 sec: https://www.inpharmd.com/provider_signup/new

Then if you like it, pester away!

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#49

Post by ereinertsen »

Ashish, I've long been a fan of your work and am excited to see you share InpharmD here.

1. What are your thoughts about partnering or selling to pharma / biotech / R&D orgs? Is there a potential value prop?

2. How does this compete with or complement existing clinical informatics and medical librarian capacity at academic medical centers? Or are they not the target market because they already pay salaries for humans to do these tasks? How do above entities relate to what the PharmDs do?

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#50

Post by aadvani »

ereinertsen wrote: post #49

Ashish, I've long been a fan of your work and am excited to see you share InpharmD here. 1. What are your thoughts about partnering or selling to pharma / biotech / R&D orgs? Is there a potential value prop? 2. How does this compete with or complement existing clinical informatics and medical librarian capacity at academic medical centers? Or are they not the target market because they already pay salaries for humans…

Excellent questions and thank you for the kind words :-)

1. We tested this with Pfizer last year and found there was an opportunity to supplement existing med info teams that do the same thing.

But it’s tough to do two markets well at once, so we decided to focus on health systems for now.

We also find that in hospitals, everyone thinks they’re asking b unique questions, but they aren’t. We can be much cheaper vs their pharmacists and still make money. Pharma companies already have standard responses so it’s a totally different value prop.

2. We don’t really compete with clinical folks at hospitals, most will readily off load this to us, so they can spend more time on patient care. There are some that like to own this, and I totally get why, but we eventually win them over. As for medical librarians, they’re great for article requests but for complex clinical questions we think a clinical pharmacist is the right type of researcher.

Post reply on HN